Flanders Vaccine Pitch & Match Session

13 Jun 2024 | Park Inn by Radisson Leuven

ServiceUpdated on 27 May 2024

Nonclinical development support

Eddy Rommel

Managing Director and Founder at Rommel Consulting Partners

Jodoigne, Brabant wallon, Belgium

About

  1. Identification and evaluation of possible CROs to conduct preclinical studies

    • Provide a short list of possible CROs based on our experience and knowledge of the environment

    • Identify and preselect candidate CROs based on their experience in the particular type of studies and animal models as well as on their cost estimates

    • Audit preferred candidates to verify their expertise as well as their scientific and regulatory (GLP, animal welfare) compliance

  2. Studies preparation and monitoring

  • Review study protocols prepared by CROs

  • Provide assistance and advice during studies in case of unexpected events or observations

  • Review studies preliminary results

  • Review draft studies reports

Type

  • Research & Development
  • Consulting
  • Coaching

Applies to

  • Animal health
  • Human health
  • Preventive vaccines
  • Therapeutic vaccines
  • Immunotherapy
  • Pandemic preparedness

Similar opportunities

  • Service

    Nonclinical development plans and gap analysis

    • Others
    • Consulting
    • Human health
    • Animal health
    • Immunotherapy
    • Preventive vaccines
    • Therapeutic vaccines
    • Pandemic preparedness
    • Research & Development

    Eddy Rommel

    Managing Director and Founder at Rommel Consulting Partners

    Jodoigne, Brabant wallon, Belgium

  • Service

    Regulatory affairs support

    • Coaching
    • Consulting
    • Human health
    • Animal health
    • Immunotherapy
    • Preventive vaccines
    • Therapeutic vaccines
    • Pandemic preparedness
    • Research & Development

    Eddy Rommel

    Managing Director and Founder at Rommel Consulting Partners

    Jodoigne, Brabant wallon, Belgium

  • Service

    Biobank Storage and Research

    • Diagnostics
    • Human health
    • Immunotherapy
    • Therapeutic vaccines
    • Research & Development

    François Côte

    Business Developer at CER Groupe

    Aye, Belgium